Cargando…
Gag Mutations Strongly Contribute to HIV-1 Resistance to Protease Inhibitors in Highly Drug-Experienced Patients besides Compensating for Fitness Loss
Human immunodeficiency virus type 1 (HIV-1) resistance to protease inhibitors (PI) results from mutations in the viral protease (PR) that reduce PI binding but also decrease viral replicative capacity (RC). Additional mutations compensating for the RC loss subsequently accumulate within PR and in Ga...
Autores principales: | Dam, Elisabeth, Quercia, Romina, Glass, Bärbel, Descamps, Diane, Launay, Odile, Duval, Xavier, Kräusslich, Hans-Georg, Hance, Allan J., Clavel, François |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652074/ https://www.ncbi.nlm.nih.gov/pubmed/19300491 http://dx.doi.org/10.1371/journal.ppat.1000345 |
Ejemplares similares
-
Role of Gag in HIV Resistance to Protease Inhibitors
por: Clavel, François, et al.
Publicado: (2010) -
High-resolution structures of HIV-1 Gag cleavage mutants determine structural switch for virus maturation
por: Mattei, Simone, et al.
Publicado: (2018) -
Computational Identification of Novel Amino-Acid Interactions in HIV Gag via Correlated Evolution
por: Kalinina, Olga V., et al.
Publicado: (2012) -
Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type
por: Matsuoka, Saori, et al.
Publicado: (2009) -
Coordinated changes of HIV-1 Gag and Env during assembly and maturation
por: Kräusslich, Hans-Georg
Publicado: (2013)